Roivant director awarded 10,531 options at $39.57
Roivant Sciences granted director equity awards of RSUs and stock options that fully vest in September 2027, increasing his direct Common Share holdings.
Rhea-AI Filing Summary
Roivant Sciences Ltd. (ROIV) reported that director Oren Ilan received equity awards on September 16, 2026 under the company's 2021 Equity Incentive Plan and Non-Employee Director Compensation Policy. He was granted 10,531 stock options to purchase Common Shares at an exercise price of $39.57 per share, expiring on September 15, 2036, and 5,054 restricted stock units (RSUs) covering Common Shares. Both the RSUs and the stock options are scheduled to vest 100% on September 16, 2027, subject to his continued service as a director. Following the RSU grant, he directly owned 123,680 Common Shares.
Positive
- None.
Negative
- None.
Insider Trade Summary
Grant/Award: 15,585 shares
Grant/Award
2 txns
Insider
Oren Ilan
Role
Director
| Type | Security | Shares | Price | Value |
|---|---|---|---|---|
| Grant/Award | Stock Option (Right to Buy) F2 | 10,531 | $0.00 | $0.00 |
| Grant/Award | Common Shares F1 | 5,054 | $0.00 | $0.00 |
Holdings After Transaction:
Stock Option (Right to Buy) — 10,531 contracts (Direct);
Common Shares — 123,680 shares (Direct)
Footnotes (2)
- F1. Reflects an annual award of restricted stock units with respect to Common Shares ("RSUs") granted pursuant to the Company's 2021 Equity Incentive Plan and the Company's Non-Employee Director Compensation Policy. The award of RSUs is scheduled to vest 100% on September 16, 2027, subject generally to the reporting person's service as a director through such date.
- F2. Reflects an annual award of stock options to purchase Common Shares granted pursuant to the Company's 2021 Equity Incentive Plan and the Company's Non-Employee Director Compensation Policy. The award of stock options is scheduled to vest and become exercisable 100% on September 16, 2027, subject generally to the reporting person's service as a director through such date.
Key Figures
Stock options granted: 10,531 options
Stock option exercise price: $39.57 per share
Stock option expiration date: September 15, 2036
+3 more
6 metrics
Stock options granted
10,531 options
Annual stock option award granted September 16, 2026
Stock option exercise price
$39.57 per share
Exercise price for 10,531 options granted to purchase Common Shares
Stock option expiration date
September 15, 2036
Expiration of options granted September 16, 2026
RSUs granted
5,054 RSUs
Annual RSU award with respect to Common Shares granted September 16, 2026
Vesting date for RSUs and options
September 16, 2027
Both RSUs and options scheduled to vest 100% on this date
Common Shares held after transaction
123,680 shares
Direct Common Share holdings after RSU grant
Key Terms
restricted stock units, Equity Incentive Plan, Non-Employee Director Compensation Policy, stock options
4 terms
restricted stock units financial
"Reflects an annual award of restricted stock units with respect to Common Shares"
Restricted stock units are a type of company reward where employees are promised shares of stock, but they only fully own these shares after meeting certain conditions, like staying with the company for a set time. They matter because they can become valuable assets and are often used to motivate employees to help the company succeed.
Equity Incentive Plan financial
"granted pursuant to the Company's 2021 Equity Incentive Plan"
An equity incentive plan is a program that gives employees, executives or directors the right to receive company stock or options to buy stock as part of their pay. Think of it as offering slices of future company profit to motivate people to boost long‑term performance; for investors it matters because it can align employee goals with shareholder value but also increases the number of shares outstanding, which can dilute existing ownership.
Non-Employee Director Compensation Policy financial
"and the Company's Non-Employee Director Compensation Policy"
stock options financial
"Reflects an annual award of stock options to purchase Common Shares"
Stock options are agreements that give a person the right to buy or sell a company's stock at a specific price within a certain time frame. They are often used as a reward or incentive, similar to a coupon that can be used later if the stock price rises, allowing the holder to make a profit.
FAQ
AI-generated questions and answers. How Rhea-AI works. Not financial advice.
What equity awards did Roivant Sciences (ROIV) director Oren Ilan receive on September 16, 2026?
He received 10,531 stock options to purchase Common Shares at $39.57 per share, expiring September 15, 2036, and an annual grant of 5,054 RSUs covering Common Shares, all under the 2021 Equity Incentive Plan and Non-Employee Director Compensation Policy.
When do the new RSUs and stock options for ROIV director Oren Ilan vest?
Both the RSUs and stock options are scheduled to vest and become exercisable 100% on September 16, 2027, generally subject to his continued service as a director through that date.
What is the exercise price and expiration date of the new Roivant Sciences (ROIV) stock options?
The annual stock option award covers 10,531 Common Shares at an exercise price of $39.57 per share and is scheduled to expire on September 15, 2036.
Were the Roivant Sciences (ROIV) equity awards to director Oren Ilan made under a Rule 10b5-1 plan?
The filing indicates the Rule 10b5-1 checkbox is not affirmed for these transactions, and the footnotes describe them as annual awards under the 2021 Equity Incentive Plan and Non-Employee Director Compensation Policy.
AI-generated analysis. How Rhea-AI works. Not financial advice.
